Heart Disease News and Research

Latest Heart Disease News and Research

EMRs aid study of genetic variants influencing human susceptibility to peripheral arterial disease

Scientific research published in the current issue of the Journal of the American Medical Informatics Association (JAMIA) reports on a study of genetic variants that influence human susceptibility to peripheral arterial disease (PAD), made possible by leveraging electronic medical records (EMRs; also called EHRs or electronic health records).

9 Sep 2010

Experts examine impact of two cardiac rescue strategies: chest compressions first vs. defibrillation first

Chest compressions before defibrillation in patients with sudden cardiac arrest is equally successful as immediate treatment with an electrical defibrillator, according to a new study by the University of Michigan Health System.

9 Sep 2010

Researchers find increase in death risk among childhood cancer survivors

Childhood cancer survivors may have an increased risk of death from other forms of cancer, cardiac and cerebrovascular causes more than 25 years after their initial illness, UK scientists have found.

9 Sep 2010

NewCardio publishes Cardio3KG clinical study for acute cardiac diagnosis

NewCardio a cardiac diagnostic technology provider, announced today that a clinical study of the Cardio3KG in acute cardiac diagnosis has been published in the August 2010 issue of the peer-reviewed journal, Heart Rhythm, the official journal of the Heart Rhythm Society.

9 Sep 2010

Cachexia reduces function and changes muscle structure of heart in mice with colon cancer

The wasting disease associated with some cancers that is typically seen affecting skeletal muscles can also cause significant damage to the heart, new research in mice suggests.

9 Sep 2010

Low carbohydrate diet rich in plant-based fats and proteins associated with lower risk of mortality

Those who adhered to a diet low in carbohydrates but rich in animal-based fats and proteins increased their risk of death – especially by cancer, according to a study published in the Annals of Internal Medicine, led by Simmons College nutrition professor Teresa Fung, Sc. D.

9 Sep 2010

Santarus, VeroScience enter agreement to commercialize CYCLOSET drug for type 2 diabetes

Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.

9 Sep 2010

Insulin may reduce life-threatening bacterial infections in intensive care patients

Treating intensive care patients who develop life-threatening bacterial infections, or septicemia, with insulin potentially could reduce their chances of succumbing to the infection, if results of a new preliminary study can be replicated in a larger study.

9 Sep 2010

Researchers discover low levels of DHA associated with chronic neurodegenerative disease

UC Irvine researchers have discovered that markedly depleted amounts of an omega-3 fatty acid in brain tissue samples from Alzheimer's patients may be due to the liver's inability to produce the complex fat, also contained in fish-oil supplements.Low levels of docosahexaenoic acid, or DHA, have been associated with the chronic neurodegenerative disease affecting millions of Americans, but no cause had been identified.

9 Sep 2010

Texas Children's Hospital implants FDA approved transcatheter pulmonary heart valve

Using a newly FDA approved pulmonary valve, Dr. Frank Ing, director of the catheterization laboratory at Texas Children's Hospital and his team of pediatric interventional cardiologists implanted a transcatheter pulmonary heart valve into the heart of a 13-year-old girl, which spared her from having her chest opened for a third heart surgery.

9 Sep 2010

Researchers synthesize new compounds to reduce A-beta 42 peptide in Alzheimer's disease

A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease (AD).

9 Sep 2010

Ohio State University receives five-year grant to improve drug therapy using gene profiles

The National Institute of General Medical Sciences has awarded a $9.1 million, five-year grant to The Ohio State University for a study titled "Expression Genetics in Drug Therapy." The goal of the research is to enhance drug response rates and reduce the number of adverse drug reactions among patients taking medication.

9 Sep 2010

Consumer Reports rates heart bypass surgical groups

The New York Times: Consumer Reports will rate groups that perform heart bypass surgery. The group already rates many consumer items like cars and even household appliances. "In most parts of the country, data-based ratings of doctors are not available to patients. Only a few states, including New York, provide them.

9 Sep 2010

Arcapita enters equity investment, option to purchase agreement with St. Jude Medical

Arcapita, a global investment company, announced today that Atlanta-based CardioMEMS, an Arcapita Ventures portfolio company, has entered into an equity investment and option to purchase agreement with St. Jude Medical, a global medical device company.

9 Sep 2010

Shared needle at school science experiment puts students at risk

In a science experiment at a Tasmanian Dover District high school, a teacher took blood samples from grade 9 and 10 students using the same needle. They were testing blood pH levels. Now students are being tested for HIV infection. The needle was dipped in methylated spirits each time before pricking but authorities say this is not enough to prevent transmission of HIV and other viruses like Hepatitis B and C.

8 Sep 2010

MAP Pharmaceuticals completes 12 months of treatment in LEVADEX open-label safety trial

MAP Pharmaceuticals, Inc. today announced that all non-asthmatic patients and a subset of asthmatic patients have completed 12 months of treatment in the open-label safety trial of LEVADEX™. In addition, the Company has completed patient treatment in a thorough QT trial, the last trial necessary to support a New Drug Application (NDA) for LEVADEX.

8 Sep 2010

MAP Pharmaceuticals reports results from PD trial that compares effects of LEVADEX, IV DHE

MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.

8 Sep 2010

Columbus Regional Hospital joins Indiana Network for Patient Care

Columbus Regional Hospital is bringing the nation's largest health information exchange to the Columbus, Ind. area to better serve patients. Joining over 65 hospitals, long term care facilities and other healthcare providers, Columbus Regional Hospital is now part of a statewide network that allows physicians to securely access necessary information to make decisions critical to patient care.

8 Sep 2010

McLeod Health implements Merge Healthcare's radiology, cardiology workflow solutions

Merge Healthcare, a leading health IT solutions provider, today announced a new contract with McLeod Health (Florence, SC). This agreement integrates the Merge cardiology workflow solutions with McLeod's existing Merge radiology solution, allowing McLeod to streamline workflow and improve quality data across their entire cardiovascular service line, while also providing a unified image management platform.

8 Sep 2010

First Edition: September 8, 2010

In today's headlines, reports about how health reform is playing on the campaign trail and the latest on health insurance premium hikes.

8 Sep 2010

Heart Disease News and Research

Latest Heart Disease News and Research

EMRs aid study of genetic variants influencing human susceptibility to peripheral arterial disease

Experts examine impact of two cardiac rescue strategies: chest compressions first vs. defibrillation first

Researchers find increase in death risk among childhood cancer survivors

NewCardio publishes Cardio3KG clinical study for acute cardiac diagnosis

Cachexia reduces function and changes muscle structure of heart in mice with colon cancer

Low carbohydrate diet rich in plant-based fats and proteins associated with lower risk of mortality

Santarus, VeroScience enter agreement to commercialize CYCLOSET drug for type 2 diabetes

Insulin may reduce life-threatening bacterial infections in intensive care patients

Researchers discover low levels of DHA associated with chronic neurodegenerative disease

Texas Children's Hospital implants FDA approved transcatheter pulmonary heart valve

Researchers synthesize new compounds to reduce A-beta 42 peptide in Alzheimer's disease

Ohio State University receives five-year grant to improve drug therapy using gene profiles

Consumer Reports rates heart bypass surgical groups

Arcapita enters equity investment, option to purchase agreement with St. Jude Medical

Shared needle at school science experiment puts students at risk

MAP Pharmaceuticals completes 12 months of treatment in LEVADEX open-label safety trial

MAP Pharmaceuticals reports results from PD trial that compares effects of LEVADEX, IV DHE

Columbus Regional Hospital joins Indiana Network for Patient Care

McLeod Health implements Merge Healthcare's radiology, cardiology workflow solutions

First Edition: September 8, 2010

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Heart Disease News and Research

Latest Heart Disease News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in